Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis
- PMID: 38414355
- DOI: 10.1017/S0033291724000199
Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis
Abstract
Background: There is limited evidence as to whether the immune protein profile is associated with a particular symptomatology pattern across the psychosis continuum.
Methods: We estimated two bifactor models of general and specific dimensions of psychotic experiences in unaffected siblings of patients (n = 52) and community controls (n = 200), and of psychotic symptoms in first-episode psychosis (FEP) patients (n = 110). We evaluated associations between these transdiagnostic dimensions and trait (TNF-α, IFN-γ), state (IL-6, IL-1β), and regulatory (TGF-β, IL-10, IL-4) cytokines. We explored whether schizophrenia genetic liability (schizophrenia polygenic risk score; SZ-PRS) modified the associations.
Results: High levels of trait marker IFN-γ were associated with the severity of general psychosis dimension in the unaffected siblings and community controls, expanding to the depressive dimension in siblings and to the manic dimension in FEP. High TNF-α levels were associated with more positive psychotic experiences in unaffected siblings and manic symptoms in FEP. Low levels of state markers IL-6 and IL-1β were observed in unaffected siblings presenting more depressive experiences. Still, high levels of IL-6 and IL-1β were associated with the severity of the depressive and negative symptom dimensions at FEP. The severity of transdiagnostic dimension scores across the three groups was associated with lower regulatory cytokines. Exploratory analysis suggested that a high SZ-PRS contributed mostly to associations with psychotic dimensions.
Conclusions: IFN-γ mapped onto the multidimensional expression of psychosis, reinforcing the trait concept. State markers IL-6 and IL-1β may fluctuate along the spectrum. Dysfunction in the regulatory arm may disinhibit the inflammatory system. Associations with psychotic dimensions may be more prone to SZ-PRS susceptibility.
Keywords: inflammation; psychosis continuum; psychotic experiences; schizophrenia; siblings.
Similar articles
-
Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment.Psychol Med. 2020 May;50(7):1139-1147. doi: 10.1017/S0033291719001016. Epub 2019 May 8. Psychol Med. 2020. PMID: 31064423
-
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.Transl Psychiatry. 2021 Aug 10;11(1):423. doi: 10.1038/s41398-021-01526-0. Transl Psychiatry. 2021. PMID: 34376640 Free PMC article.
-
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis.Transl Psychiatry. 2024 Oct 26;14(1):454. doi: 10.1038/s41398-024-03149-7. Transl Psychiatry. 2024. PMID: 39461938 Free PMC article.
-
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.Brain Behav Immun. 2019 Feb;76:268-274. doi: 10.1016/j.bbi.2018.11.315. Epub 2018 Nov 26. Brain Behav Immun. 2019. PMID: 30496778 Free PMC article.
-
Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.Schizophr Bull. 2019 Jun 18;45(4):742-751. doi: 10.1093/schbul/sby125. Schizophr Bull. 2019. PMID: 30169868 Free PMC article.
Cited by
-
Variations in inflammatory regulators in male patients with chronic schizophrenia associated with psychopathology and cognitive deficits.BMC Psychiatry. 2024 Nov 15;24(1):811. doi: 10.1186/s12888-024-06288-9. BMC Psychiatry. 2024. PMID: 39548412 Free PMC article.
-
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels.Biol Psychiatry Glob Open Sci. 2024 Dec 2;5(2):100429. doi: 10.1016/j.bpsgos.2024.100429. eCollection 2025 Mar. Biol Psychiatry Glob Open Sci. 2024. PMID: 39911538 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical